Forward Ventures

The record

Every round we can evidence, newest first38 appearances

1. 2015

   1 round

2. Aug
   Syndax PharmaceuticalsSeries C · US$80MWith 12 others
3. 2013

   2 rounds

4. Sept
   Affinium PharmaceuticalsDebt · US · canadianprivateequity.com$12MWith 2 others
5. Aug
   Syndax PharmaceuticalsSeries B · US · finsmes.com$27MWith 3 others
6. 2012

   2 rounds

7. Nov
   Ambit BiosciencesVenture · US · phx.corporate-ir.net$50MWith 8 others
8. Mar
   HemaQuest PharmaceuticalsSeries B · US · hemaquest.com$13MWith 4 others
9. 2011

   2 rounds

10. Aug
    Affinium PharmaceuticalsSeries B · US · afnm.com$15MWith 2 others
11. Jun
    Ambit BiosciencesSeries D · US · phx.corporate-ir.net$30MWith 9 others
12. 2010

    5 rounds

13. Jun
    Nereus PharmaceuticalsSeries E · US · onbiovc.com$20MWith 6 others
14. Apr
    HemaQuest PharmaceuticalsSeries B · US · fiercebiotech.com$12MWith 3 others
15. Mar
    Syndax PharmaceuticalsSeries A · US · onbiovc.com$9.0MWith 4 others
16. Feb
    Tioga PharmaceuticalsSeries A · US · tiogapharma.com$18MWith 3 others
17. Feb
    Altair TherapeuticsSeries B · US · onbiovc.com$17MWith 3 others
18. 2009

    1 round

19. Aug
    LigoCyte PharmaceuticalsSeries C · US$29MWith 3 others
20. 2008

    1 round

21. Apr
    LigoCyte PharmaceuticalsSeries B · US$28MWith 3 others
22. 2007

    9 rounds

23. Nov
    Ambit BiosciencesSeries D · US$49MWith 11 others
24. Nov
    HemaQuest PharmaceuticalsSeries A · US$20MWith 2 others
25. Nov
    AsteresSeries C · US · venturedeal.com$4.0MWith 2 others
26. Sept
    Sequel PharmaceuticalsSeries A · US$20MWith 4 others
27. Aug
    Nereus PharmaceuticalsSeries D · US$45MWith 12 others
28. Apr
    Syndax PharmaceuticalsSeries A · US$40MWith 4 others
29. Mar
    Affinium PharmaceuticalsSeries A · US$18MWith 3 others
30. Feb
    Sanarus MedicalSeries E · US · deals.venturebeat.com$15MWith 6 others
31. Jan
    Proprius PharmaceuticalsSeries A · US$11MWith 4 others
32. 2006

    3 rounds

33. Oct
    Concurrent ThinkingVenture · GB$3.2MWith 2 others
34. Sept
    NovaCardiaSeries B · US$48MWith 5 others
35. Jan
    Tioga PharmaceuticalsSeries A · US · tiogapharma.com$24MWith 2 others
36. 2005

    4 rounds

37. Oct
    Nereus PharmaceuticalsSeries D · US$43MWith 11 others
38. Aug
    AdianaSeries D · US · allbusiness.com$23MWith 8 others
39. May
    Ambit BiosciencesSeries C · US$31MWith 6 others
40. Jan
    Predix PharmaceuticalsSeries C$43MWith 10 others
41. 2004

    2 rounds

42. Feb
    MorphotekSeries C · US$26MWith 9 others
43. Jan
    TargeGenSeries B · US$30MWith 4 others
44. 2003

    3 rounds

45. Nov
    Sanarus MedicalSeries C · US$19MWith 5 others
46. May
    Acorda TherapeuticsSeries C · US$55MWith 6 others
47. Mar
    HypnionSeries B · US$48MWith 8 others
48. 2002

    2 rounds

49. Nov
    KemiaSeries A · US$17MSole investor
50. Jan
    Gryphon TherapeuticsSeries B$26MWith 2 others
51. 2001

    1 round

52. Jul
    Sanarus MedicalSeries B · US$14MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed7 in all

An exit counts when it came after the firm's first round in the company. From historical deal records.